Chemistry Wealth Management’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ORCL
Chemistry Wealth Management's ORCL Position: Q2 2026 in Review
Chemistry Wealth Management reduced its Oracle (ORCL) stake by 30% in Q2 2026, selling an estimated $182K and leaving 2,381 shares worth $349K. The position accounts for 0.06% of the portfolio, ranked #160.
Chemistry Wealth Management first reported a position in ORCL in Q1 2022 and has held it in 18 quarters since. The position peaked at $9.43M in Q3 2025. 1,772 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.
- Chemistry Wealth Management held 2,381 shares of Oracle worth $349K as of Q2 2026.
- Chemistry Wealth Management sold 1,005 Oracle shares in Q2 2026, an estimated $182K.
- Oracle made up 0.06% of Chemistry Wealth Management's portfolio in Q2 2026, its #160 holding.
- Chemistry Wealth Management first reported a position in Oracle in Q1 2022 and has held it in 18 quarters since.
- Chemistry Wealth Management's Oracle position peaked at $9.43M in Q3 2025.
- 1,772 funds tracked by Wall St. Rank held Oracle as of Q2 2026.
Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.